Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents

Junfang Li,Xiaohong Fan,Jiedan Deng,Yan Liang,Shumeng Ma,Yingmei Lu,Jian Zhang,Tao Shi,Wen Tan,Zhen Wang
DOI: https://doi.org/10.1016/j.bmc.2020.115526
IF: 3.461
2020-01-01
Bioorganic & Medicinal Chemistry
Abstract:A series of 1,3-benzothiazinone derivatives were designed and synthesized for pharmacological assessments. Among the synthesized 19 compounds, some compounds showed high activities on inhibiting LPS-induced nitrite oxide and TNF-alpha production, down-regulating COX-2 and increasing IL-10 production in RAW264.7 cells. All the compounds had no obvious cytotoxicity in in vitro assay. LD50 value of compound 25 was greater than 2000 mg/kg, which was safer than meloxicam. Compound 25 significantly inhibited phosphorylation of NF-kappa B and STAT3 in LPS-induced RAW264.7 cells. Inhibition of synthesized compounds on COX activity was weaker than meloxicam. Compound 25 displayed lower gastrointestinal toxicity than meloxicam. Besides, compound 25 decreased the swelling in carrageenan-induced paw edema models of inflammation and reduced PGE(2) level significantly. In summary, 1,3-benzothiazinone derivatives are unique scaffolds with anti-inflammatory activity and low toxicity.
What problem does this paper attempt to address?